Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yancen Guo"'
Autor:
Yuxiu Zhao, Zhenyu He, Zhanhui Wang, Yao He, Xue Zhao, Hongyang Liang, Yancen Guo, Yichuan Wang, Xiaonan Zhang, Huiqin Zhu, Yuan Dong, Yingwei Liu, Wanli Li, Ling Ding, Xiujuan Zhu, Haoyue Lan, Yuntao Zhang, Hui Wang, Xiaoming Yang
Publikováno v:
COVID, Vol 3, Iss 1, Pp 51-64 (2022)
Due to a large number of mutations in the spike protein and immune escape, the Omicron variant (B.1.1.529) has become a predominant variant of concern (VOC) strain. To prevent the disease, we developed a candidate inactivated vaccine (Omicron COVID-1
Externí odkaz:
https://doaj.org/article/b012d86b6a5146d7820d98e652b32458
Autor:
Zhaona Yang, Shouzhi Yu, Ying Xu, Yuxiu Zhao, Lili Li, Jingjie Sun, Xin Wang, Yancen Guo, Yuntao Zhang
Publikováno v:
Diseases, Vol 12, Iss 1, p 20 (2024)
Influenza is a potentially fatal acute respiratory viral disease caused by the influenza virus. Influenza viruses vary in antigenicity and spread rapidly, resulting in seasonal epidemics. Vaccination is the most effective strategy for lowering the in
Externí odkaz:
https://doaj.org/article/8a01be6a826e406daf9c4ef10f562dab
Autor:
Yuntao Zhang, Yancen Guo, Yuan Dong, Yingwei Liu, Yuxiu Zhao, Shouzhi Yu, Shihui Li, Chongyang Wu, Baifeng Yang, Wanli Li, Xiaoli Wei, Yadan Zhang, Yunchao Huang, Hui Wang, Xiaoming Yang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022)
The DTacP-sIPV-Hib combination vaccine can replace the single-component acellular pertussis, diphtheria, tetanus, polio, and Haemophilus influenzae type B vaccines. In this study, we evaluated the safety and immunogenicity of a newly developed DTacP-
Externí odkaz:
https://doaj.org/article/e12a58a1412f4d3eb2d5f2829f57fbcb
Autor:
Shouzhi Yu, Yunchao Huang, Chongyang Wu, Weibin Fu, Hongyang Liang, Chen Chen, Yue Cheng, Yancen Guo, Ying Zhang, Hui Wang, Xiaoming Yang
Publikováno v:
Cells, Vol 11, Iss 21, p 3396 (2022)
Cell detachment techniques using animal-derived enzymes are necessary for the production of biopharmaceuticals that are made with the help of adherent cell cultures, although the majority of protein therapeutics (>USD 100 billion of income per year)
Externí odkaz:
https://doaj.org/article/a4e64d5156a14a48ac32fe7494e66424
Autor:
Yuntao Zhang, Wenjie Tan, Zhiyong Lou, Yuxiu Zhao, Jin Zhang, Hongyang Liang, Na Li, Xiujuan Zhu, Ling Ding, Baoying Huang, Weimin Zhou, Yancen Guo, Zhaona Yang, Yuling Qiao, Zhenyu He, Bo Ma, Yao He, Di Zhu, Zhanhui Wang, Zhen Chang, Xue Zhao, Wei Wang, Ying Xu, Huiqin Zhu, Xiaotong Zheng, Chenlong Wang, Guangxue Xu, Guizhen Wu, Hui Wang, Xiaoming Yang
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1149 (2022)
In response to the fast-waning immune response and the great threat of the Omicron variant of concern (VOC) to the public, we report the pilot-scale production of an inactivated Omicron vaccine candidate that induces high levels of neutralizing antib
Externí odkaz:
https://doaj.org/article/2bf8f861e184439aa2795f24f8dadba9
Autor:
Yuntao Zhang, Wenjie Tan, Zhiyong Lou, Baoying Huang, Weimin Zhou, Yuxiu Zhao, Jin Zhang, Hongyang Liang, Na Li, Xiujuan Zhu, Ling Ding, Yancen Guo, Zhenyu He, Yao He, Zhanhui Wang, Bo Ma, Meng Ma, Suhua Zhao, Zhen Chang, Xue Zhao, Xiaotong Zheng, Guizhen Wu, Hui Wang, Xiaoming Yang
Publikováno v:
Vaccines, Vol 10, Iss 6, p 956 (2022)
It has been reported that the novel coronavirus (COVID-19) has caused more than 286 million cases and 5.4 million deaths to date. Several strategies have been implemented globally, such as social distancing and the development of the vaccines. Severa
Externí odkaz:
https://doaj.org/article/f73ed644cc874be1b02c26830e790a5c